In low transmission settings, a similar number of additional cases are averted per dose across target age groups, with a slight trend to higher impact when targeting school-aged children (from 5 to 9 or 14 years of age) (Fig. 1 ).
← all excerpts
Public health impact of catch-up vaccination or additional booster doses with pre-erythrocytic malaria vaccine R21/Matrix-M: a modelling study.
1
—
—